|
TRUB1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.33749999999966E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.51940000000717E-05 |
| Normal-vs-Stage2 |
3.893000E-01 |
| Normal-vs-Stage3 |
5.462400E-01 |
| Normal-vs-Stage4 |
9.911000E-01 |
| Stage1-vs-Stage2 |
2.156000E-01 |
| Stage1-vs-Stage3 |
8.827500E-02 |
| Stage1-vs-Stage4 |
1.211190E-01 |
| Stage2-vs-Stage3 |
8.253800E-01 |
| Stage2-vs-Stage4 |
5.685800E-01 |
| Stage3-vs-Stage4 |
7.151600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.65640000000722E-05 |
| Normal-vs-AfricanAmerican |
9.304500E-02 |
| Normal-vs-Asian |
6.879000E-01 |
| Caucasian-vs-AfricanAmerican |
5.647400E-01 |
| Caucasian-vs-Asian |
5.057000E-01 |
| AfricanAmerican-vs-Asian |
8.079400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.05350000232119E-08 |
| Normal-vs-Female |
7.490800E-01 |
| Male-vs-Female |
3.445300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.528600E-01 |
| Normal-vs-Extreme_Weight |
4.59340000480424E-08 |
| Normal-vs-Obese |
1.015600E-03 |
| Normal-vs-Extreme_Obese |
4.131200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.218100E-02 |
| Normal_Weight-vs-Obese |
3.032400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.667000E-01 |
| Extreme_Weight-vs-Obese |
8.947900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.837800E-01 |
| Obese-vs-Extreme_Obese |
6.823000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.075000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.936000E-03 |
| Normal-vs-Age(61-80Yrs) |
4.09900000000185E-05 |
| Normal-vs-Age(81-100Yrs) |
3.158000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.132800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.048750E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.328770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.068800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.289400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.809600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.47639999909566E-08 |
| Normal-VS-Type2 PRCC |
3.128400E-01 |
| Normal-VS-KIRP CIMP |
3.666000E-01 |
| Normal-VS-Unclassified PRCC |
1.115020E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.050200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.064580E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.730400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.631400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.502400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.770400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.360900E-03 |
| Normal-vs-N1 |
6.243200E-01 |
| Normal-vs-N2 |
7.855600E-02 |
| N0-vs-N1 |
4.508400E-02 |
| N0-vs-N2 |
9.017800E-01 |
| N1-vs-N2 |
4.097400E-01 |
|
|
